<VariationArchive VariationID="11061" VariationName="NM_000252.3(MTM1):c.605del (p.Leu202fs)" VariationType="Deletion" Accession="VCV000011061" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-01-26" DateCreated="2017-01-06" MostRecentSubmission="2017-01-06">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26100" VariationID="11061">
      <GeneList>
        <Gene Symbol="MTM1" FullName="myotubularin 1" GeneID="4534" HGNC_ID="HGNC:7448" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="150562653" stop="150673143" display_start="150562653" display_stop="150673143" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="149737046" stop="149841615" display_start="149737046" display_stop="149841615" Strand="+" />
          </Location>
          <OMIM>300415</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MTM1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MTM1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000252.3(MTM1):c.605del (p.Leu202fs)</Name>
      <CanonicalSPDI>NC_000023.11:150641341:TTTT:TTT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="150641342" stop="150641342" display_start="150641342" display_stop="150641342" variantLength="1" positionVCF="150641341" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="149809815" stop="149809815" display_start="149809815" display_stop="149809815" variantLength="1" positionVCF="149809814" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>L202fs</ProteinChange>
      <ProteinChange>L165fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.149809818del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.149809818del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.150641345del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.150641345del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008199.1" sequenceAccession="NG_008199" sequenceVersion="1" change="g.77772del">
            <Expression>NG_008199.1:g.77772del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000252.3" sequenceAccession="NM_000252" sequenceVersion="3" change="c.605del" MANESelect="true">
            <Expression>NM_000252.3:c.605del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000243.1" sequenceAccession="NP_000243" sequenceVersion="1" change="p.Leu202fs">
            <Expression>NP_000243.1:p.Leu202fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001376906.1" sequenceAccession="NM_001376906" sequenceVersion="1" change="c.605del">
            <Expression>NM_001376906.1:c.605del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001363835.1" sequenceAccession="NP_001363835" sequenceVersion="1" change="p.Leu202fs">
            <Expression>NP_001363835.1:p.Leu202fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001376907.1" sequenceAccession="NM_001376907" sequenceVersion="1" change="c.494del">
            <Expression>NM_001376907.1:c.494del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001363836.1" sequenceAccession="NP_001363836" sequenceVersion="1" change="p.Leu165fs">
            <Expression>NP_001363836.1:p.Leu165fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001376908.1" sequenceAccession="NM_001376908" sequenceVersion="1" change="c.605del">
            <Expression>NM_001376908.1:c.605del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001363837.1" sequenceAccession="NP_001363837" sequenceVersion="1" change="p.Leu202fs">
            <Expression>NP_001363837.1:p.Leu202fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_839" sequenceAccession="LRG_839">
            <Expression>LRG_839:g.77772del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_839t1" sequenceAccession="LRG_839t1">
            <Expression>LRG_839t1:c.605del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_839p1" sequenceAccession="LRG_839p1" change="p.Leu202fs">
            <Expression>LRG_839p1:p.Leu202fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="672601325" DB="dbSNP" />
        <XRef ID="CA255675" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="300415.0009" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000252.3(MTM1):c.605del (p.Leu202fs) AND Severe X-linked myotubular myopathy" Accession="RCV000011810" Version="11">
        <ClassifiedConditionList TraitSetID="1981">
          <ClassifiedCondition DB="MedGen" ID="C0410203">Severe X-linked myotubular myopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2003-04-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2003-04-22" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-01-06" MostRecentSubmission="2017-01-06">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12707446</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1981" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5607" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Myotubular myopathy, X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe X-linked myotubular myopathy</ElementValue>
                <XRef ID="Severe+x-linked+myotubular+myopathy/9289" DB="Genetic Alliance" />
                <XRef ID="46804001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MYOTUBULAR MYOPATHY 1</ElementValue>
                <XRef Type="MIM" ID="310400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked centronuclear myopathy</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CNMX</ElementValue>
                <XRef Type="MIM" ID="310400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MTMX</ElementValue>
                <XRef Type="MIM" ID="310400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XLMTM</ElementValue>
                <XRef Type="MIM" ID="310400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MTM1</ElementValue>
                <XRef Type="MIM" ID="310400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="11925" />
                <XRef ID="11925" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">X-linked myotubular myopathy (X-MTM), also known as myotubular myopathy (MTM), is characterized by muscle weakness that ranges from severe to mild. Approximately 80% of affected males present with severe (classic) X-MTM characterized by polyhydramnios, decreased fetal movement, and neonatal weakness, hypotonia, and respiratory failure. Motor milestones are significantly delayed and most individuals fail to achieve independent ambulation. Weakness is profound and often involves facial and extraocular muscles. Respiratory failure is nearly uniform, with most individuals requiring 24-hour ventilatory assistance. It is estimated that at least 25% of boys with severe X-MTM die in the first year of life, and those who survive rarely live into adulthood. Males with mild or moderate X-MTM (~20%) achieve motor milestones more quickly than males with the severe form; many ambulate independently, and may live into adulthood. Most require gastrostomy tubes and/or ventilator support. In all subtypes of X-MTM, the muscle disease is not obviously progressive. Female carriers of X-MTM are generally asymptomatic, although manifesting heterozygotes are increasingly being identified. In affected females, symptoms range from severe, generalized weakness presenting in childhood, with infantile onset similar to affected male patients, to mild (often asymmetric) weakness manifesting in adulthood. Affected adult females may experience progressive respiratory decline and ultimately require ventilatory support.</Attribute>
                <XRef ID="NBK1432" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301605</ID>
                <ID Source="BookShelf">NBK1432</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2012">
                <ID Source="PubMed">22617344</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Frase, 2016">
                <URL>http://online.liebertpub.com/doi/10.1089/hum.2016.29024.arf</URL>
              </Citation>
              <XRef ID="596" DB="Orphanet" />
              <XRef ID="C0410203" DB="MedGen" />
              <XRef ID="MONDO:0010683" DB="MONDO" />
              <XRef Type="MIM" ID="310400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32043" SubmissionDate="2016-12-14" DateLastUpdated="2017-01-06" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300415.0009_MYOTUBULAR MYOPATHY, X-LINKED" title="MTM1, 1-BP DEL, 605T_MYOTUBULAR MYOPATHY, X-LINKED" />
        <ClinVarAccession Accession="SCV000032043" DateUpdated="2017-01-06" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-04-22">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Schara et al. (2003) reported a female with prenatal/neonatal onset of clinical symptoms due to myotubular myopathy (CNMX; 310400). During pregnancy, fetal movements were reduced. After birth, she showed severe hypotonia, dyspnea, a weak cry, absent tendon reflexes, a high-arched palate, and a right-sided ptosis. She later had limb-girdle and facial muscle weakness and a waddling gait. Skeletal muscle biopsy showed a wide variation of fiber size and numerous internal nuclei. Direct sequencing of the MTM1 gene showed a heterozygous frameshift mutation, 605delT. Schara et al. (2003) noted the more severe clinical course in this female compared to other reported affected females and emphasized the prenatal onset of symptoms.</Attribute>
              <Citation>
                <ID Source="PubMed">12707446</ID>
              </Citation>
              <XRef DB="OMIM" ID="310400" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MTM1" />
          </GeneList>
          <Name>MTM1, 1-BP DEL, 605T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 605T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300415.0009" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MYOTUBULAR MYOPATHY, X-LINKED</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32043" TraitType="Disease" MappingType="Name" MappingValue="MYOTUBULAR MYOPATHY, X-LINKED" MappingRef="Preferred">
        <MedGen CUI="C0410203" Name="Severe X-linked myotubular myopathy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

